CartiHeal, a privately-held medical device company with headquarters in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.
CartiHeal’s cell-free, off-the-shelf implant is CE marked for use in cartilage and osteochondral defects. Agili-C has been implanted in over 400 patients with cartilage lesions in the knee, ankle and great toe in a series of trials conducted in leading centers in Europe and Israel. In these trials, the implant was used to treat a broad spectrum of cartilage lesions, from single focal lesions to multiple and large defects in patients suffering from osteoarthritis.
In the United States the Agili-C implant is not available for sale - it is an investigational device limited for use in the IDE study.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 17 Atir Yeda, Kfar Saba,israel 4464313,israel
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.cartiheal.com
- HQ
- Kfar Saba, Israel
Cartiheal Questions
Cartiheal's website is http://www.cartiheal.com
Cartiheal's LinkedIn profile is https://www.linkedin.com/company/cartiheal
Cartiheal has
18 employees.
View email and phone details for 18
employees at Cartiheal.
Cartiheal's industry is
Medical Equipment Manufacturing
Cartiheal's top competitors are
Smith+nephew,
V-Wave,
Shockwave Medical,
Lima Corporate,
Endomag, A Hologic Company,
Axonics, Inc.,
Endotronix,
Silk Road Medical, Inc.,
Jenavalve Technology, Inc.,
Laminar, Inc..
Cartiheal's categories are Medical Equipment Manufacturing
Cartiheal's founding year is 2009
